Article
Bulk and single-cell transcriptome profiling reveal tumor-specific T-based molecular classification, tumor microenvironment infiltration characterization relevant to combination therapies in lung adenocarcinoma
2022-06-03
Abstract excerpt
<h4>Background: </h4> In lung adenocarcinoma (LUAD), the use of small-molecule inhibitors, chemotherapy and immunotherapy has led to unprecedented survival benefits in selected patients. Considering most patients will experience a relapse within a short period of time due to single drug resistance, combination therapy is also particularly important to improve patient prognosis. Therefore, more robust biomarkers to...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 71dc801a-32b3-50b0-a6fe-c31d624ef332
- DOI
- 10.21203/rs.3.rs-1710574/v1
